miR-1 Inhibits Cell Growth, Migration, and Invasion by Targeting VEGFA in Osteosarcoma Cells

Junjie Niu1, Yibao Sun2, Qiaoge Guo3

  • 1Department of Radiology, Zhengzhou Orthopedics Hospital, Zhengzhou, China.

Disease Markers
|October 26, 2016
PubMed

Insights

MicroRNAs (miRNAs) act as tumor suppressors in osteosarcoma (OS) by inhibiting cell proliferation and metastasis. This study reveals that miR-1 directly targets VEGFA, suppressing OS progression.

Area of Science:

  • Molecular Biology
  • Oncology
  • Biochemistry

Background:

  • MicroRNAs (miRNAs) are critical regulators in cancer development, including osteosarcoma (OS).
  • Vascular Endothelial Growth Factor A (VEGFA) is implicated in tumor growth and metastasis.

Purpose of the Study:

  • To investigate the role of miR-1 in osteosarcoma (OS) progression.
  • To determine if VEGFA is a direct target of miR-1 in OS cells.

Main Methods:

  • Quantitative real-time PCR to measure miR-1 and VEGFA expression.
  • Cell proliferation, migration, and invasion assays (CCK-8, Transwell).
  • Dual-luciferase reporter assay to confirm direct targeting of VEGFA by miR-1.

Main Results:

  • miR-1 expression was significantly downregulated in OS tissues and cell lines.
  • VEGFA expression was upregulated in OS tissues and cell lines.
  • miR-1 suppressed OS cell proliferation, migration, and invasion, and directly targeted VEGFA.
  • VEGFA knockdown mimicked the tumor-suppressive effects of miR-1.

Conclusions:

  • miR-1 functions as a tumor suppressor in osteosarcoma.
  • The miR-1/VEGFA axis plays a significant role in inhibiting OS cell proliferation, migration, and invasion.

Related Concept Videos

mTOR Signaling and Cancer Progression03:03

mTOR Signaling and Cancer Progression

The mammalian target of rapamycin or mTOR protein was discovered in 1994 due to its direct interaction with rapamycin. The protein gets its name from a yeast homolog called TOR. The mTOR protein complex in mammalian cells plays a major role in balancing anabolic processes such as the synthesis of proteins, lipids, and nucleotides and catabolic processes, such as autophagy in response to environmental cues, such as availability of nutrients and growth factors.
The mTOR pathway or the...
5.0K
mTOR Signaling and Cancer Progression03:03

mTOR Signaling and Cancer Progression

1.6K
Mitogens and the Cell Cycle02:38

Mitogens and the Cell Cycle

Mitogens and their receptors play a crucial role in controlling the progression of the cell cycle. However, the loss of mitogenic control over cell division leads to tumor formation. Therefore, mitogens and mitogen receptors play an important role in cancer research. For instance, the epidermal growth factor (EGF) - a type of mitogen and its transmembrane receptor (EGFR), decides the fate of the cell's proliferation. When EGF binds to EGFR, a member of the ErbB family of tyrosine kinase...
8.3K
Metastasis02:30

Metastasis

Metastasis is the spread of cancer cells from the original site to distant locations in the body. Cancer cells can spread via blood vessels (hematogenous) as well as lymph vessels in the body.
Epithelial-to-Mesenchymal Transition
The epithelial-to-mesenchymal transition or EMT is a developmental process commonly observed in wound healing, embryogenesis, and cancer metastasis. EMT is induced by transforming growth factor-beta (TGF-β) or receptor tyrosine kinase (RTK) ligands, which further...
6.7K
Cancer Cell Migration through Invadopodia01:35

Cancer Cell Migration through Invadopodia

Invadosome is a broad category of cell surface structures with proteolytic activity that  degrades the extracellular matrix (ECM). Invadosomes are present in normal cell types, including macrophages, endothelial cells, and neurons, as well as tumor cells. Although the macrophage podosomes and tumor cell invadopodia are classified as invadosomes, they have different structures, molecular pathways, and functions. Podosomes are short structures that last for a few minutes. However,...
3.4K
Regulation of Angiogenesis and Blood Supply01:24

Regulation of Angiogenesis and Blood Supply

Rapidly dividing tumors, embryos, and wounded tissues require more oxygen than usual, lowering the oxygen concentration in the blood. At low oxygen or hypoxic conditions, an oxygen-sensitive transcription factor called the hypoxia-inducible factor 1 or HIF1 is activated. HIF1 is a dimeric protein of alpha (ɑ) and beta (β) subunits.  Under optimal oxygen conditions, HIF1β is present in the nucleus while HIF1ɑ remains in the cytosol. HIF1ɑ is hydroxylated by prolyl...
3.9K